Therefore, CD4+ T cells are important for the remodeling of tumor blood vessels and the increase of TA-HEVs, and they also control the recruitment and functional phenotype of CD8+ T cells during anti-CTLA-4 therapy. The gene discussed is CTLA4; the disease is neoplasm.